Member Info for BOJO2020

Thanks Bermuda and Ray. Great knowledge. I can always read and understand your posts which is testament to how well worded they are.

Krafty the best questions elicit the most useful answers!! Thanks.

Re: LD, she is naughty isn’t she! Often saying things like I cannot say anymore and that is as much science as I am aloud! Gives one the impression that there is much more to be said, and of course there is but the levels of complexity are mind boggling.

GF,

Some people hand over control to others (often unknowingly), some people take it (instinctively). Others that are astute do not get involved in such games and concentrate on bigger and more important things. What we witness on these bulletin boards on a daily basis is a power struggle between those that are not focused on the bigger and more important things imo.

Yes Crumbs, you have played a part in my better understanding of Scancell. Genuinely much appreciated. You have a depth of knowledge of this company that I will not even try to aspire too. However I have got a good handle on this share now so whilst I am happy to read and appreciate your post's I do not need to hang out of your coat tails any longer. That said I think this bulletin board is a better place for having you so I would certainly like to see you back like straight away. If I may offer a bit of advice... When people are throwing rocks at you just duck! They will soon run out of rocks (unless you throw them back) and get board. Also it would be a good example to set by moving on. The Modi thing was just a blip as the share price has borne out.

Ruck, according to RG, LD delved into a deep pile of scientific papers on that plane to the USA. Who else on this board reads scientific papers do you think? To gain an unrivalled knowledge might have read everything and anything? Which posters do you think? Yet CW is targeted for doing the same? By posters that ain’t that scientific it seems

C11,

So you would value these, "relevant and helpful posts," above clinical trial evidence as communicated yesterday? Above peer reviewed articles, an RNS communicating for instance - a new delivery method, a research/broker note?

C11,

Are you really comparing the formal communication of significant trial data to the market to ANY post made on a public bulletin board over the last weeks and months?

EE mentioned yesterday that we will see where this is at over the coming weeks.

I think with Milan, the trial protocol being amended to accommodate ISCIB1+ and just the fact the market needs to digest these fine SCOPE results that is a fair comment.

I do look at Avacta and wonder why we are not around the same share price. Are they overvalued, are we undervalued. Probably a bit if both. Anyways, facts and data will drive this. Scancell are doing their part. Should be a steady ride from here imo.

Never in doubt!

The danger for non scientific types like me is that it is hard to asses progress data and what it means going forward. However, I think it is safe to say that this data is highly encouraging and most importantly is shown to work over a period of time. Noted that patient 9 in the spider graph (slide no6) was the only patient PR section (10 patients) that saw the tumor shrink, grow, and then overall shrinkage.

Thanks Bermuda,

Thinking about things. Very smart of Scancell to involve Modi 1 with checkpoint inhibitors it would seem...

ISCIB1+ trial approval should also give us a boost. That news should be announced very soon imo.

Rigga,

I thought you wrote, 'has this got logs for the rest of the week.' ;)

Yes WTP agree. In fact there has been a lot of gloom spread lately and little hype. Yet still we rise!

Hi TF,

I do not have a beef with anyone and I am very chilled about Scancell.

However a few points for perspective

1. People have money invested here (an obvious point I know)

2. Any credible post will be valued (notice future tense)

I do not do hierarchical groups. I do not think either Bermuda or crumbs post for any other reason than to benefit others. However any contributor is only as good as their last post. We simply cannot allow fondness or preference to become a factor because of point one above. I do not tick up a post just because it is by Bermuda, I tick up because I agree with or appreciate the point being made. Rallying around support for said posters is all well and good but turning on CW is not. The words we use are here for ever (unless deleted). So May posters should think on that before railing other people. A bit or decorum sometimes?

Anyway enjoy the rugby

But when you have the gift (like Superman or his big sister) you can see what other mere mortals cannot. Looking into the future, all that kind of clever stuff. I think Harry Potter called it Divination? Can't remember what Mystic Meg called it... Ooh ! Maybe crumbs would know? Oh hang on a bit he is not here :( Drat!

Well don't ask me I only fit windows for a living. Maybe if we all asked him very nicely he would come back so we do not have to think for ourselves. Anyway, my one brain cell is overheating and needs to rest.

Well the science is very deep and complex. The route to market equally so. I do not say this so that people feel they are somehow precluded from grasping this one. Quite the contrary, the science is full of rabbit holes and one can certainly get lost in such places. Common sense and an eye on the pennies may see you a long way! However I think we can all agree that Parsortix is the real deal. If anyone has taken the time to listen to the webcast today then it is obvious that Angle are making strides (all be it not huge ones) to link the product in useful and meaningful ways that will produce revenue. For such a long time this was not happening but we can see progress is being made.

My conclusion is that the once darling of AIM has got up off it's ass today. Sure it is leaning on one knee but the signs are there that it is about to stand up and do something.

DYOR

Goinglarge

I can sense the exitment in your words. The sheer glee! I bet you are doing a happy dance right now? Ohh, errr that is as long as you loaded up at the bottom? Hate to think you were left standing waiting for 6p

Mwhahahhahha!!!!

AB,

I think for people to react to a ongoing situation is natural. However the trial will be determined by evidence and we must wait for that. There has been a shift on Modi towards a combi trial and I get that, but because it's path was so unclear I did not invest for it. For me at least it is all about preparation (my own) and SCIB1 has evidence that it may CONTINUE to show promise in human trials. That is why I am invested. Obviously I will take any other positives from the other platforms.

Crumbs

You appear to have fallen into a Modi 1 rabbit hole all of your own making. Please provide evidence of its efficacy or lack of to back up how you have arrived at your current rational. You see, you and others have been previously very keen on Modi 1 and vocal about it. But with insufficient data thus far from the trial I think that your claims that it is a dud are completely unfounded. Just as anybody claiming it to be a success would be equally unfounded. Further, it had only ever been proven successful in mice (unlike SCIB1). Ergo there was never any solid reason to believe that it should/could be successful in humans. It is and was only ever a gamble. The only conclusion I can arrive at is that presently you are not so keen. Therefore previously you must have been keener? Changing ones mind is fine but suggesting why on a public forum without any evidence is not. It just gives you the appearance that your confused.

SCIB1 is our strongest candidate. At least it has form (evidence from actual human trials) that we can judge it by which suggest it has further potential. Covidity adds to the Immunobody data case. Modi 1 is in the process of being proven via human trials so cannot be judged and should not be judged by anyone other than those involved in the trial. We can hope for a further(ence) of Mabs deal(s).

So if I had to put my money on it and I have, this is all about SCIB1/iSCIB1+. The rest may add value but there is no evidence to suggest so at this time. Maybe a stronger case for Mabs but again there is absolutely no way of knowing.

DYOR

Well apart from the fact that she was featured in the local newspapers...